Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS)

Historical Holders from Q1 2020 to Q4 2025

Type / Class
Equity / Class A common stock, $0.0001 par value per share
Symbol
HIMS on NYSE
Shares outstanding
219,713,074
Price per share
$32.47
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
199,813,829
Total reported value
$11,329,228,091
% of total 13F portfolios
0.01%
Share change
+23,673,920
Value change
+$1,433,600,109
Avg buy value change
+0.01%
Avg sell value change
-0.02%
Number of holders
504
Price from insider filings
$33.79
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Dudum Andrew 10% $1,050,978,329 23,820,905 Andrew Dudum 07 Aug 2025
BlackRock, Inc. 11% $617,891,866 23,047,067 BlackRock, Inc. 31 Mar 2025
Capital World Investors 8.6% $818,836,404 18,559,302 Capital World Investors 30 Jun 2025
JPMORGAN CHASE & CO 8.1% $1,009,432,170 17,796,759 JPMORGAN CHASE & CO. 30 Sep 2025
As of 30 Sep 2025, Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS) has 504 institutional shareholders filing 13F forms. They hold 199,813,829 shares. of 219,713,074 outstanding shares (91%) .

Top 25 institutional shareholders own 75% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 11% 25,145,814 +1.6% 0.03% $1,426,270,569
VANGUARD GROUP INC 8.9% 19,518,015 +4.5% 0.02% $1,107,061,811
Capital World Investors 8.5% 18,783,194 +1.2% 0.15% $1,065,398,873
JPMORGAN CHASE & CO 8.1% 17,786,085 +549% 0.06% $1,008,826,798
FARALLON CAPITAL MANAGEMENT LLC 4.9% 10,746,852 +31% 3.4% $609,561,445
GOLDMAN SACHS GROUP INC 4.2% 9,223,511 +13% 0.08% $523,157,543
RENAISSANCE TECHNOLOGIES LLC 4.1% 9,096,852 +32% 0.68% $515,973,445
MORGAN STANLEY 3.3% 7,276,096 +32% 0.02% $412,700,318
STATE STREET CORP 3.3% 7,173,214 +1.9% 0.01% $406,864,698
GEODE CAPITAL MANAGEMENT, LLC 2.2% 4,900,814 +3.3% 0.02% $278,539,033
Invesco Ltd. 1.9% 4,152,409 +63% 0.04% $235,524,638
PRICE T ROWE ASSOCIATES INC /MD/ 1.4% 3,068,129 +444% 0.02% $174,025,000
UBS Group AG 1.3% 2,864,030 +12% 0.03% $162,447,782
Tidal Investments LLC 1.3% 2,859,233 +1780% 0.69% $162,175,696
NORTHERN TRUST CORP 1.1% 2,415,158 +1.4% 0.02% $136,987,761
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 2,355,439 +46% 0.02% $133,600,500
JANE STREET GROUP, LLC 1% 2,242,228 +197% 0.15% $127,179,173
BIT Capital GmbH 1% 2,210,384 +77% 5.7% $125,372,980
DIMENSIONAL FUND ADVISORS LP 0.98% 2,146,977 -2.5% 0.03% $121,799,892
STATE OF MICHIGAN RETIREMENT SYSTEM 0.94% 2,057,700 +49% 0.56% $116,712,744
BANK OF MONTREAL /CAN/ 0.84% 1,843,289 +20% 0.05% $104,551,353
BANK OF AMERICA CORP /DE/ 0.82% 1,808,077 +55% 0.01% $102,554,146
BNP PARIBAS FINANCIAL MARKETS 0.78% 1,719,274 0% 0.08% $97,517,221
Clear Street Group Inc. 0.7% 1,540,401 0% 0.43% $87,371,545
Bank of New York Mellon Corp 0.61% 1,339,702 +1.1% 0.01% $75,987,916

Institutional Holders of Hims & Hers Health, Inc. - Class A common stock, $0.0001 par value per share (HIMS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 665,502 $21,768,143 +$2,143,474 3,247% 14
2025 Q3 199,813,829 $11,329,228,091 +$1,433,600,109 5,672% 504
2025 Q2 175,272,406 $8,737,551,985 +$961,577,302 4,985% 502
2025 Q1 156,242,521 $4,616,101,567 -$171,576,908 2,955% 416
2024 Q4 164,166,677 $3,970,228,258 +$665,448,988 2,418% 384
2024 Q3 136,884,700 $2,523,698,550 +$6,863,639 1,842% 304
2024 Q2 130,151,551 $2,628,079,824 +$213,696,425 2,019% 299
2024 Q1 127,014,197 $1,964,665,504 +$98,319,259 1,547% 237
2023 Q4 4,125,226 $36,714,513 -$28,683,285 890% 4
2023 Q3 112,407,576 $707,008,830 -$96,878,484 629% 188
2023 Q2 123,233,037 $1,158,446,738 +$123,883,766 940% 183
2023 Q1 111,348,583 $1,103,941,338 +$69,328,106 992% 183
2022 Q4 104,576,481 $670,336,307 +$193,272,055 641% 148
2022 Q3 94,710,366 $528,471,197 +$33,249,221 558% 142
2022 Q2 88,985,730 $401,730,372 +$44,067,288 453% 130
2022 Q1 77,685,245 $414,023,018 -$14,825,263 533% 126
2021 Q4 70,002,682 $458,482,840 +$15,104,242 655% 136
2021 Q3 42,308,384 $318,980,142 -$102,714,254 753.98% 105
2021 Q2 54,477,774 $592,929,452 +$19,734,652 1,088.97% 83
2021 Q1 52,489,322 $692,963,000 +$689,551,400 1,322.98% 80
2020 Q4 186,615 $2,725,000 +$2,725,008 1,460.23% 1
2020 Q1 4,000 $53,000 $0 1,325% 1